AI Skin Scanners Lack Sufficient Accuracy to Replace Professional Dermatological Examinations

The German drugstore chain dm is venturing into a new territory, introducing AI-assisted skin analysis in selected stores. This service, provided by the partner Dermanostic, offers an MDR-certified telemedicine product in dermatology.

While AI systems are already trained to detect specific features like melanomas, an "all-in-one" solution covering all aspects of skin analysis is not yet available. The AI in dm's skin analysis service can make certain skin changes visible and quantify aspects like pigment deposits, elasticity, or UV damage.

However, the German Association of Dermatologists (BVDD) has criticized the offer, warning against false diagnoses and a "sales gimmick". They argue that linking the skin analysis service with product recommendations could potentially link health to consumption, a serious dermatology approach should not involve a shopping list after an AI analysis.

The service can help patients become aware of skin damage and take preventive action. However, it is crucial to remember that any mole assessed as harmless by the AI could potentially be an early skin tumor and should always be examined by a dermatologist. The dm skin analysis service should not replace a medical examination, and the limits of AI in skin diagnostics are clear.

Risks for users of dm's AI-assisted skin examination include unregulated skin checks outside the statutory health system, potentially leading to uncontrolled or inaccurate diagnoses and delayed professional medical treatment for serious skin conditions. The biggest risk for users is a false sense of security, as current AI systems are not capable of reliably detecting skin cancer.

Online-available scanners that provide a "skin age" are not reliable, as it is not a valid measure of skin health. Skin age is more of a marketing tool rather than an accurate representation of skin health.

The offer could put a long-term strain on dermatological practices, as anxious patients might visit already busy practices. The BVDD President, Ralph von Kiedrowski, and the German Medical Journal have voiced this concern.

Despite these concerns, using artificial intelligence for skin diagnostics has opportunities. AI can potentially serve as a wake-up call about skin damage, but it can also lead to a false sense of security or unnecessary purchases. The evaluation aims to provide indications about the skin condition and is linked to product recommendations for dm own brands.

In conclusion, while the dm AI-assisted skin analysis service offers a novel approach to skin health monitoring, it is essential to approach it with caution. It should not replace professional medical advice and should be used as a tool for increased awareness and preventive action.

AI Skin Scanners Lack Sufficient Accuracy to Replace Professional Dermatological Examinations